Copyright Reports & Markets. All rights reserved.

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Cystic Fibrosis (Mucoviscoidosis) Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cystic Fibrosis (Mucoviscoidosis) Testing by Type
    • 1.3.1 Overview: Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value Market Share by Type in 2023
    • 1.3.3 Chest Physical Therapy (CPT)
    • 1.3.4 Consumption Of Antibiotics
    • 1.3.5 Lung Transplant And Postural Drainage
  • 1.4 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market by Application
    • 1.4.1 Overview: Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Ambulatory Surgical Centers
    • 1.4.4 Others
  • 1.5 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size & Forecast
  • 1.6 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast by Region
    • 1.6.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region, (2019-2030)
    • 1.6.3 North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Vertex Pharmaceuticals
    • 2.1.1 Vertex Pharmaceuticals Details
    • 2.1.2 Vertex Pharmaceuticals Major Business
    • 2.1.3 Vertex Pharmaceuticals Cystic Fibrosis (Mucoviscoidosis) Testing Product and Solutions
    • 2.1.4 Vertex Pharmaceuticals Cystic Fibrosis (Mucoviscoidosis) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Vertex Pharmaceuticals Recent Developments and Future Plans
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott Cystic Fibrosis (Mucoviscoidosis) Testing Product and Solutions
    • 2.2.4 Abbott Cystic Fibrosis (Mucoviscoidosis) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Abbott Recent Developments and Future Plans
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Cystic Fibrosis (Mucoviscoidosis) Testing Product and Solutions
    • 2.3.4 Pfizer Cystic Fibrosis (Mucoviscoidosis) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Pfizer Recent Developments and Future Plans
  • 2.4 NovaBiotics
    • 2.4.1 NovaBiotics Details
    • 2.4.2 NovaBiotics Major Business
    • 2.4.3 NovaBiotics Cystic Fibrosis (Mucoviscoidosis) Testing Product and Solutions
    • 2.4.4 NovaBiotics Cystic Fibrosis (Mucoviscoidosis) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 NovaBiotics Recent Developments and Future Plans
  • 2.5 Cystic Fibrosis Foundation
    • 2.5.1 Cystic Fibrosis Foundation Details
    • 2.5.2 Cystic Fibrosis Foundation Major Business
    • 2.5.3 Cystic Fibrosis Foundation Cystic Fibrosis (Mucoviscoidosis) Testing Product and Solutions
    • 2.5.4 Cystic Fibrosis Foundation Cystic Fibrosis (Mucoviscoidosis) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Cystic Fibrosis Foundation Recent Developments and Future Plans
  • 2.6 Galapagos
    • 2.6.1 Galapagos Details
    • 2.6.2 Galapagos Major Business
    • 2.6.3 Galapagos Cystic Fibrosis (Mucoviscoidosis) Testing Product and Solutions
    • 2.6.4 Galapagos Cystic Fibrosis (Mucoviscoidosis) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Galapagos Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cystic Fibrosis (Mucoviscoidosis) Testing by Company Revenue
    • 3.2.2 Top 3 Cystic Fibrosis (Mucoviscoidosis) Testing Players Market Share in 2023
    • 3.2.3 Top 6 Cystic Fibrosis (Mucoviscoidosis) Testing Players Market Share in 2023
  • 3.3 Cystic Fibrosis (Mucoviscoidosis) Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Cystic Fibrosis (Mucoviscoidosis) Testing Market: Region Footprint
    • 3.3.2 Cystic Fibrosis (Mucoviscoidosis) Testing Market: Company Product Type Footprint
    • 3.3.3 Cystic Fibrosis (Mucoviscoidosis) Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Type (2019-2030)
  • 6.2 North America Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Application (2019-2030)
  • 6.3 North America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country
    • 6.3.1 North America Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Type (2019-2030)
  • 7.2 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Application (2019-2030)
  • 7.3 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country
    • 7.3.1 Europe Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 7.3.3 France Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Region
    • 8.3.1 Asia-Pacific Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Region (2019-2030)
    • 8.3.2 China Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 8.3.5 India Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Type (2019-2030)
  • 9.2 South America Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Application (2019-2030)
  • 9.3 South America Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country
    • 9.3.1 South America Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Market Size by Country
    • 10.3.1 Middle East & Africa Cystic Fibrosis (Mucoviscoidosis) Testing Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cystic Fibrosis (Mucoviscoidosis) Testing Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cystic Fibrosis (Mucoviscoidosis) Testing Market Drivers
  • 11.2 Cystic Fibrosis (Mucoviscoidosis) Testing Market Restraints
  • 11.3 Cystic Fibrosis (Mucoviscoidosis) Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cystic Fibrosis (Mucoviscoidosis) Testing Industry Chain
  • 12.2 Cystic Fibrosis (Mucoviscoidosis) Testing Upstream Analysis
  • 12.3 Cystic Fibrosis (Mucoviscoidosis) Testing Midstream Analysis
  • 12.4 Cystic Fibrosis (Mucoviscoidosis) Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cystic Fibrosis (Mucoviscoidosis) Testing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thick and sticky mucus. The disease develops over a period of time in the lungs and blocks the tubes that carry air in and out. Increased secretion of thick mucus accelerates the growth of bacteria and hence, gives rise to serious lung infections. Some of the major symptoms of cystic fibrosis include persistent cough, constant lung infection, salty tasting skin, problem in breathing, bulky stools, difficulty in bowel movements, poor growth and poor weight gain. Some of the tests available for cystic fibrosis are newborn screening, sweat test, chest x-ray, lung function tests, and genetic testing. Cystic fibrosis can be divided into three segments, namely, cystic fibrosis mutations, curable type of cystic fibrosis, and rare type of cystic fibrosis. Some of the treatment methods for cystic fibrosis are chest physical therapy (CPT), exercise, consumption of antibiotics, lung transplant and postural drainage.
    Major driving factors for the growth of the cystic fibrosis market are increasing number of patients suffering from cystic fibrosis, rising need and demand for sophisticated testing tools, and increased government funding for the development of genetic testing. Moreover, every company wants to grow and develop by using pharmacogenomic diagnostic tools, so that they have an enviable position in the existing market. Rapid adoption of potentially advanced tests to diagnose cystic fibrosis and increasing awareness and affordability of the people across geographies will continually provide growth towards this market. On the other hand, factors like huge amount of capital involved and few adverse effects like pulmonary exacerbations and weight gain would most likely impede the growth of this market.
    The Global Info Research report includes an overview of the development of the Cystic Fibrosis (Mucoviscoidosis) Testing industry chain, the market status of Hospitals (Chest Physical Therapy (CPT), Consumption Of Antibiotics), Ambulatory Surgical Centers (Chest Physical Therapy (CPT), Consumption Of Antibiotics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cystic Fibrosis (Mucoviscoidosis) Testing.
    Regionally, the report analyzes the Cystic Fibrosis (Mucoviscoidosis) Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cystic Fibrosis (Mucoviscoidosis) Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Cystic Fibrosis (Mucoviscoidosis) Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cystic Fibrosis (Mucoviscoidosis) Testing industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Chest Physical Therapy (CPT), Consumption Of Antibiotics).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cystic Fibrosis (Mucoviscoidosis) Testing market.
    Regional Analysis: The report involves examining the Cystic Fibrosis (Mucoviscoidosis) Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cystic Fibrosis (Mucoviscoidosis) Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Cystic Fibrosis (Mucoviscoidosis) Testing:
    Company Analysis: Report covers individual Cystic Fibrosis (Mucoviscoidosis) Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cystic Fibrosis (Mucoviscoidosis) Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).
    Technology Analysis: Report covers specific technologies relevant to Cystic Fibrosis (Mucoviscoidosis) Testing. It assesses the current state, advancements, and potential future developments in Cystic Fibrosis (Mucoviscoidosis) Testing areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cystic Fibrosis (Mucoviscoidosis) Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Cystic Fibrosis (Mucoviscoidosis) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Chest Physical Therapy (CPT)
    Consumption Of Antibiotics
    Lung Transplant And Postural Drainage
    Market segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Others
    Market segment by players, this report covers
    Vertex Pharmaceuticals
    Abbott
    Pfizer
    NovaBiotics
    Cystic Fibrosis Foundation
    Galapagos
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Cystic Fibrosis (Mucoviscoidosis) Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Cystic Fibrosis (Mucoviscoidosis) Testing, with revenue, gross margin and global market share of Cystic Fibrosis (Mucoviscoidosis) Testing from 2019 to 2024.
    Chapter 3, the Cystic Fibrosis (Mucoviscoidosis) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cystic Fibrosis (Mucoviscoidosis) Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Cystic Fibrosis (Mucoviscoidosis) Testing.
    Chapter 13, to describe Cystic Fibrosis (Mucoviscoidosis) Testing research findings and conclusion.

    Buy now